Nasdaq biol.

LAKE FOREST, Calif., March 17, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the fourth quarter and full year ...BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the closing of its previously announced underwritten public offering of 175,000 units ...Graphite Bio, Inc. (Nasdaq – GRPH) Under the terms of the agreement, Graphite Bio will merge with LENZ Therapeutics in an all-stock transaction. Under the …Dec 5, 2023 · BIOL) stock’s latest price update. Biolase Inc (NASDAQ: BIOL) has experienced a rise in its stock price by 31.30 compared to its previous closing price of 1.15. However, the company has seen a gain of 30.17% in its stock price over the last five trading days. Benzinga reported 2023-08-04 that The most oversold stocks in the health care sector ... BIOL Sales Forecast. Next quarter’s sales forecast for BIOL is $14.75M with a range of $13.35M to $16.70M. The previous quarter’s sales results were $10.92M. BIOL beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 46.34% of the time in the same period.

To maintain listing, the Nasdaq Capital Market requires, among other things, that our common stock maintain a minimum closing bid price of $1.00 per share. On May 24, 2021, we received a deficiency letter from the Nasdaq Stock Market notifying us that, for the 30 consecutive business days ended May 21, 2021, the bid price for our common stock ...Graphite Bio, Inc. (Nasdaq – GRPH) Under the terms of the agreement, Graphite Bio will merge with LENZ Therapeutics in an all-stock transaction. Under the …

Analyst Recommendations on BIOLASE, Inc. Biolase Files Registration Statement for Unit Offering at Target Price of $60 a Unit. Sep. 12. MT. Lake Street Adjusts Price Target on …FOOTHILL RANCH, Calif., Feb. 23, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, today announced that the Board of Directors has appointed John R. Beaver, the ...

BIOL. BIOLASE, Inc. 1.4750. -0.0850. -5.45%. BIOLASE Inc (NASDAQ: BIOL) and EdgeEndo have announced the co-development of EdgePRO, a next-generation Laser-Assisted Microfluidic Irrigation device ...3 Oct 2023 ... Math. Biol. Neurosci. ISSN 2052-2541. Editorial Office: [email protected]. Copyright ©2023 CMBN.LAKE FOREST, Calif., Jan. 12, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that the Company has been awarded a Top Workplaces 2022 honor ...Biolase Inc NASDAQ 1.090 -0.020 -1.80% After Hours: 1.130 +0.04 +3.67% 19:32 11/30 EST OPEN 1.140 PREV CLOSE 1.110 HIGH 1.180 LOW 1.071 VOLUME 237.58K …Nov 15, 2020 · Investors in BIOLASE, Inc. (NASDAQ:BIOL) had a good week, as its shares rose 7.1% to close at US$0.29 following the release of its third-quarter results. It was a pretty bad result overall; while ...

BIOL. BIOLASE, Inc. 1.4750. -0.0850. -5.45%. BIOLASE Inc (NASDAQ: BIOL) and EdgeEndo have announced the co-development of EdgePRO, a next-generation Laser-Assisted Microfluidic Irrigation device ...

/PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for its third quarter ended September...

Shift workers, especially those that work all night and sleep during the day, have long since been associated with many cardiovascular diseases like hypertension, diabetes, obesity and even sleep disorders.1 Many of the associated risks ari...LAKE FOREST, Calif., May 11, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the first quarter ended March 31, 2023 ...These institutions hold a total of 1 shares. Largest shareholders include Huntington National Bank . Biolase Inc (NASDAQ:BIOL) institutional ownership structure ...The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestigious of the three. The NASDAQ is a virtual stock exchange.About · Highlight. A world's leading dental laser company. Industry · Exchange. NASDAQ · Listing Date. 11/12/1992 · Established Date · Full-time Employees.Nasdaq News: This is the News-site for the company Nasdaq on Markets Insider Indices Commodities Currencies Stocks

The BIOL share has a YTD performance of -22% and a 52-week price range of $0.37 - $10.4. The stock has experienced positive momentum due to a solid revenue report in Q4 2022. With a stock price below $1, the stock may provide great value to investors considering a positive outlook for 2023. Best place to buy BIOL: RobinhoodAt just 47 cents a share, BIOL stock is in danger of being delisted by the Nasdaq, which requires companies to maintain a minimum share price of $1 to remain on the exchange. However, in a news ...Jun 5, 2023 · BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced that its Board of Directors declared a dividend of one one-thousandth of a share of ... BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release second quarter 2023 financial and operating results on Thursday, August 10, 2023, after the ...The Nasdaq Capital Market requires, among other things, that a listing a company's common stock maintain a minimum bid price of at least $1.00 per share. Information for BIOLASE Stockholders

FOOTHILL RANCH, Calif., Sept. 11, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that Todd Norbe, President and Chief Executive Officer and ...

LAKE FOREST, Calif., Jan. 10, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering consisting of 16,453,569 shares of its common stock and pre-funded warrants to purchase 11,403,571 shares of common stock at a public offering price of $0.35 per share or $0.34 per pre ...Biolase Inc (NASDAQ:BIOL) $1.165 -0.075 [-6.05%] Last update: 3:45PM (Delayed 15-Minutes) Get Real Time Here $1.17 0.0050 [0.43%] Profile News Analyst …Dec 5, 2023 · BIOL) stock’s latest price update. Biolase Inc (NASDAQ: BIOL) has experienced a rise in its stock price by 31.30 compared to its previous closing price of 1.15. However, the company has seen a gain of 30.17% in its stock price over the last five trading days. Benzinga reported 2023-08-04 that The most oversold stocks in the health care sector ... Nelly Dodson. December 4, 2023. Technologies. Biolase Inc (NASDAQ:BIOL) has a beta value of 1.20 and has seen 1.07 million shares traded in the recent trading session. The company, currently valued at $3.29M, closed the recent trade at $1.43 per share which meant it gained $0.28 on the day or 24.35% during that session.May 2, 2022 · Find the latest news headlines from Biolase, Inc. Common Stock (BIOL) at Nasdaq.com. On Nov. 3, Korro Bio (NASDAQ: KRRO) used Frequency Therapeutics' Nasdaq listing to reverse merge into U.S. public markets. Korro's stock price soared …

BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants. LAKE FOREST, Calif. , Sept. 13, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public ...

Larry N Feinberg, the manager of Oracle Associates, has opened a position in BIOLASE Inc (NASDAQ: BIOL).In a recent filing with the Securities and Exchange Commission, Mr. Feinberg disclosed ...

FOOTHILL RANCH, Calif., Feb. 1, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, encourages stockholders to vote their shares with respect to the adjourned ...Nov 29, 2023 · What is BIOLASE's consensus rating and price target? According to the issued ratings of 2 analysts in the last year, the consensus rating for BIOLASE stock is Buy based on the current 2 buy ratings for BIOL. The average twelve-month price prediction for BIOLASE is $77.00 with a high price target of $150.00 and a low price target of $4.00. BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, and EdgeEndo, a global leader in commercializing endodontic products, announced the FDA 510(k) clearance of the Ed gePRO system for endodontists seeking a more effective cleaning and disinfection alternative within root canal procedures. The new laser …The answer lies in Nasdaq rules that give companies generous grace periods for companies trying to get their share price back above $1. Under the rules, a company …BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants. LAKE FOREST, Calif. , Sept. 13, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public ...The firm earned $10.92 million during the quarter. BIOLASE has generated ($158.82) earnings per share over the last year ( ($158.82) diluted earnings per share). BIOLASE has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 26th, 2024 based off prior year's report dates.May 26, 2023 · BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the closing of its previously announced underwritten public offering of 175,000 units ... LAKE FOREST, Calif., Aug. 31, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced a strategic plan to partner with postgraduate dental specialty ...(NASDAQ: BIOL), the global leader in dental lasers, announced today the U.S. launch of the Waterlase Fractional Handpiece for doctors seeking a faster and more efficient way to perform skin ...

BIOL After-Hours Quotes. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary ... Posted by Techdows on Nov 30th, 2023. StockNews.com lowered shares of BIOLASE ( NASDAQ:BIOL – Free Report) from a hold rating to a sell rating in a report issued on Wednesday. Separately, Benchmark cut their price objective on shares of BIOLASE from $10.00 to $4.00 in a research report on Wednesday, September 20th. Get BIOLASE alerts:Nov 15, 2020 · Investors in BIOLASE, Inc. (NASDAQ:BIOL) had a good week, as its shares rose 7.1% to close at US$0.29 following the release of its third-quarter results. It was a pretty bad result overall; while ... Instagram:https://instagram. consumer staples etfsbroadcome stockurbn incmsft ai The latest price target for . Biolase (NASDAQ: BIOL) was reported by Lake Street on Wednesday, May 31, 2023.The analyst firm set a price target for 0.40 expecting BIOL to fall to within 12 months ... inexpensive stocks with high dividendsfree cryptos How much is Biolase stock worth today? ( NASDAQ: BIOL) Biolase currently has 2,296,777 outstanding shares. With Biolase stock trading at $1.25 per share, the total value of Biolase stock (market capitalization) is $2.87M. Biolase stock was originally listed at a price of $38,049.71 in Dec 31, 1997. aiq dividend Track Biolase Inc (BIOL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsBIOLASE, Inc. 17 Nov, 2021, 16:05 ET. FOOTHILL RANCH, Calif., Nov. 17, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, encourages stockholders to vote TODAY ...